+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

Ataxia Market Report 2025 - Product Thumbnail Image

Ataxia Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
GLP-1 Receptor Agonist Market Report 2025 - Product Thumbnail Image

GLP-1 Receptor Agonist Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Antibody Drug Conjugates Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Antibody Drug Conjugates Market - Forecasts from 2024 to 2029

  • Report
  • February 2024
  • 210 Pages
  • Global
From
From
From
From
Retinoblastoma Treatment Market - Product Thumbnail Image

Retinoblastoma Treatment Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Parathyroid Hormone Market Report 2025 - Product Thumbnail Image

Parathyroid Hormone Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Neuroendocrine Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

Neuroendocrine Tumors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 280 Pages
  • Global
From
From
Relapsing-Remitting Multiple Sclerosis - Pipeline Insight, 2025 - Product Thumbnail Image

Relapsing-Remitting Multiple Sclerosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
From
Loading Indicator